Novartis AG (NVS) saw its stock rise by 4.20% on June 11, driven by positive results from its FORTITUDE Phase I/II study for del-brax, an investigatio...
Neutral
BNP Paribas Financial Markets cut its stake in Novartis AG (NYSE:NVS – Free Report) by 59.1% in the fourth quarter, HoldingsChannel reports. The insti...
Novartis announced that data from its Cosentyx(R) clinical trial for Polymyalgia Rheumatica (PMR) were published in The New England Journal of Medicin...
Neutral
Grandfield & Dodd LLC lessened its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 4.6% during the fourth quarter, according to the comp...